273 related articles for article (PubMed ID: 20837299)
1. Age and comedications influence levetiracetam pharmacokinetics in children.
Dahlin MG; Wide K; Ohman I
Pediatr Neurol; 2010 Oct; 43(4):231-5. PubMed ID: 20837299
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic variability of four newer antiepileptic drugs, lamotrigine, levetiracetam, oxcarbazepine, and topiramate: a comparison of the impact of age and comedication.
Johannessen Landmark C; Baftiu A; Tysse I; Valsø B; Larsson PG; Rytter E; Johannessen SI
Ther Drug Monit; 2012 Aug; 34(4):440-5. PubMed ID: 22777154
[TBL] [Abstract][Full Text] [Related]
3. Age and antiepileptic drugs influence topiramate plasma levels in children.
Dahlin MG; Ohman IK
Pediatr Neurol; 2004 Oct; 31(4):248-53. PubMed ID: 15464635
[TBL] [Abstract][Full Text] [Related]
4. Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy.
Otoul C; De Smedt H; Stockis A
Epilepsia; 2007 Nov; 48(11):2111-5. PubMed ID: 17651416
[TBL] [Abstract][Full Text] [Related]
5. Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproate.
Fountain NB; Conry JA; Rodríguez-Leyva I; Gutierrez-Moctezuma J; Salas E; Coupez R; Stockis A; Lu ZS
Epilepsy Res; 2007 Apr; 74(1):60-9. PubMed ID: 17270398
[TBL] [Abstract][Full Text] [Related]
6. Effect of age and comedication on levetiracetam pharmacokinetics and tolerability.
Hirsch LJ; Arif H; Buchsbaum R; Weintraub D; Lee J; Chang JT; Resor SR; Bazil CW
Epilepsia; 2007 Jul; 48(7):1351-9. PubMed ID: 17573925
[TBL] [Abstract][Full Text] [Related]
7. The effects of co-medications on lamotrigine clearance in Japanese children with epilepsy.
Takeuchi T; Natsume J; Kidokoro H; Ishihara N; Yamamoto H; Azuma Y; Ito Y; Kurahashi N; Tsuji T; Suzuki M; Itomi K; Yamada K; Kurahashi H; Abe S; Okumura A; Maruyama K; Negoro T; Watanabe K; Kojima S
Brain Dev; 2016 Sep; 38(8):723-30. PubMed ID: 27033151
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Drug Monitoring of Levetiracetam and Lamotrigine: Is There a Need?
Naik GS; Kodagali R; Mathew BS; Thomas M; Prabha R; Mathew V; Fleming DH
Ther Drug Monit; 2015 Aug; 37(4):437-44. PubMed ID: 25478905
[TBL] [Abstract][Full Text] [Related]
9. Rufinamide in children with refractory epilepsy: pharmacokinetics, efficacy, and safety.
Dahlin MG; Ohman I
Neuropediatrics; 2012 Oct; 43(5):264-70. PubMed ID: 22941776
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of levetiracetam in infants and young children with epilepsy.
Glauser TA; Mitchell WG; Weinstock A; Bebin M; Chen D; Coupez R; Stockis A; Lu ZS
Epilepsia; 2007 Jun; 48(6):1117-22. PubMed ID: 17442002
[TBL] [Abstract][Full Text] [Related]
11. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
Perucca E; Cloyd J; Critchley D; Fuseau E
Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics of levetiracetam and dosing recommendation in children with epilepsy.
Chhun S; Jullien V; Rey E; Dulac O; Chiron C; Pons G
Epilepsia; 2009 May; 50(5):1150-7. PubMed ID: 19175400
[TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetics of levetiracetam in Japanese and Western adults.
Pigeolet E; Jacqmin P; Sargentini-Maier ML; Stockis A
Clin Pharmacokinet; 2007; 46(6):503-12. PubMed ID: 17518509
[TBL] [Abstract][Full Text] [Related]
14. Zonisamide: pharmacokinetics, efficacy, and adverse events in children with epilepsy.
Wallander KM; Ohman I; Dahlin M
Neuropediatrics; 2014 Dec; 45(6):362-70. PubMed ID: 25133701
[TBL] [Abstract][Full Text] [Related]
15. Levetiracetam therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs.
Contin M; Albani F; Riva R; Baruzzi A
Ther Drug Monit; 2004 Aug; 26(4):375-9. PubMed ID: 15257066
[TBL] [Abstract][Full Text] [Related]
16. Effect of levetiracetam on the pharmacokinetics of adjunctive antiepileptic drugs: a pooled analysis of data from randomized clinical trials.
Gidal BE; Baltès E; Otoul C; Perucca E
Epilepsy Res; 2005; 64(1-2):1-11. PubMed ID: 15823510
[TBL] [Abstract][Full Text] [Related]
17. Effect of antiepileptic drug comedication on lamotrigine clearance.
Weintraub D; Buchsbaum R; Resor SR; Hirsch LJ
Arch Neurol; 2005 Sep; 62(9):1432-6. PubMed ID: 16157751
[TBL] [Abstract][Full Text] [Related]
18. The ideal pharmacokinetic properties of an antiepileptic drug: how close does levetiracetam come?
Perucca E; Johannessen SI
Epileptic Disord; 2003 May; 5 Suppl 1():S17-26. PubMed ID: 12915337
[TBL] [Abstract][Full Text] [Related]
19. Influence of enzyme inducing antiepileptic drugs on the pharmacokinetics of levetiracetam in patients with epilepsy.
Freitas-Lima P; Alexandre V; Pereira LR; Feletti F; Perucca E; Sakamoto AC
Epilepsy Res; 2011 Mar; 94(1-2):117-20. PubMed ID: 21282041
[TBL] [Abstract][Full Text] [Related]
20. Influence of levetiracetam on the anticonvulsant efficacy of conventional antiepileptic drugs against audiogenic seizures in DBA/2 mice.
Donato Di Paola E; Gareri P; Davoli A; Gratteri S; Scicchitano F; Naccari C; De Sarro G
Epilepsy Res; 2007 Jul; 75(2-3):112-21. PubMed ID: 17553669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
